BNP Paribas Asset Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-290,150
Closed -$12.3M 843
2020
Q3
$12.3M Sell
290,150
-67,312
-19% -$2.9M 0.07% 295
2020
Q2
$15.5M Sell
357,462
-61,402
-15% -$2.43M 0.1% 234
2020
Q1
$13.7M Sell
418,864
-58,197
-12% -$2.16M 0.12% 215
2019
Q4
$17.6M Sell
477,061
-6,276
-1% -$223K 0.12% 223
2019
Q3
$16.2M Buy
483,337
+155,077
+47% +$5.5M 0.12% 214
2019
Q2
$12.9M Buy
328,260
+140,065
+74% +$5.55M 0.11% 252
2019
Q1
$7.63M Buy
188,195
+7,176
+4% +$268K 0.06% 359
2018
Q4
$5.83M Buy
+181,019
New +$7.31M 0.05% 412

Other funds holding FMS

BNP Paribas Asset Management's FMS Position: Q4 2020 in Review

BNP Paribas Asset Management sold out of Fresenius Medical Care (FMS) in Q4 2020, closing a stake of 290,150 shares — an estimated $12.3M sold.

BNP Paribas Asset Management first reported a position in FMS in Q4 2018 and held it in 8 quarters. The position peaked at $17.6M in Q4 2019. 178 funds tracked by Wall St. Rank hold FMS as of Q4 2020.

  • BNP Paribas Asset Management reported no remaining Fresenius Medical Care position as of Q4 2020 after selling out during the quarter.
  • BNP Paribas Asset Management sold 290,150 Fresenius Medical Care shares in Q4 2020, an estimated $12.3M.
  • BNP Paribas Asset Management first reported a position in Fresenius Medical Care in Q4 2018 and held it in 8 quarters.
  • BNP Paribas Asset Management's Fresenius Medical Care position peaked at $17.6M in Q4 2019.
  • 178 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2020.

Based on BNP Paribas Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.